This two-part CME series delves into the comorbidities and complications which make the treatment and management of psoriasis more complex. While one case focuses on the relationships among psoriasis, Hodgkin's lymphoma, and anti-tumor necrosis factor therapy, the second hones in on psoriasis, metabolic disease, and cardiovascular disease.
Participants will also learn about new therapies for treating psoriasis as well as the most appropriate treatment approaches based on individualized patient needs.
Each activity offers:
0.50 / AMA PRA Category 1 CreditTM
Release: June 20, 2018
Expiration: June 20, 2019
Released: June 20, 2018
Expires: June 20, 2019
Alan Menter, MD
Jointly provided by
These activities are supported by educational grants from